Page 44 - 《中国药房》2024年12期
P. 44

genic subpopulation with stem cell properties in melano‐  stemness  in  the  clinic:from  hype  to  hope[J].  Cell  Stem
               mas[J]. Cancer Res,2005,65(20):9328-9337.           Cell,2019,24(1):25-40.
          [ 4 ]  SHEN S Y,XU X,LIN S Q,et al. A nanotherapeutic strate-  [13]  WU Y Q,ZHUANG J B,ZHAO D,et al. Interaction be‐
               gy  to  overcome  chemotherapeutic  resistance  of  cancer   tween caspase-3 and caspase-5 in the stretch-induced pro‐
               stem-like  cells[J].  Nat  Nanotechnol,2021,16 (1) :  grammed  cell  death  in  the  human  periodontal  ligament
               104-113.                                            cells[J]. J Cell Physiol,2019,234(8):13571-13581.
          [ 5 ]  SHI S J,HAN L,GONG T,et al. Systemic delivery of mi‐  [14]  YU P,ZHANG X,LIU N,et al. Pyroptosis:mechanisms
               croRNA-34a  for  cancer  stem  cell  therapy[J].  Angew   and  diseases[J].  Signal  Transduct  Target  Ther,2021,6
               Chem Int Ed,2013,52(14):3901-3905.                 (1):128.
          [ 6 ]  SUN Y F,ZHOU Q Q,CHEN F M,et al. Berberine inhibits   [15]  WANG Q Y,WANG Y P,DING J J,et al. A bioorthogonal
               breast carcinoma proliferation and metastasis under hypoxic   system reveals antitumour immune function of pyroptosis[J].
               microenvironment  involving  gut  microbiota  and  endo-  Nature,2020,579(7799):421-426.
               genous metabolites[J]. Pharmacol Res,2023,193:106817.  [16]  ROGERS C,ERKES D A,NARDONE A,et al. Gasder‐
          [ 7 ]  李俊平,吴春芝,岳文,等. 小檗碱的临床新用途及新剂                        min pores permeabilize mitochondria to augment caspase-3
               型研究进展[J]. 中国药房,2016,27(22):3154-3158.               activation  during  apoptosis  and  inflammasome  activation
               LI J P,WU C Z,YUE W,et al. Research progress on new   [J]. Nat Commun,2019,10(1):1689.
               clinical uses and new dosage forms of berberine[J]. China   [17]  RHINN  M,DOLLÉ  P.  Retinoic  acid  signalling  during
               Pharm,2016,27(22):3154-3158.                        development[J]. Development,2012,139(5):843-858.
          [ 8 ]  ZHANG Z B,ZHANG Y,XIA S Y,et al. Gasdermin E   [18]  KIM M S,LEBRON C,NAGPAL J K,et al. Methylation
               suppresses  tumour  growth  by  activating  anti-tumour  im‐  of the DFNA5 increases risk of lymph node metastasis in
               munity[J]. Nature,2020,579(7799):415-420.           human breast cancer[J]. Biochem Biophys Res Commun,
          [ 9 ]  KANUNGO  J,CUEVAS  E,ALI  S  F,et  al.  Zebrafish   2008,370(1):38-43.
               model  in  drug  safety  assessment[J].  Curr  Pharm  Des,  [19]  WANG Y B,YIN B,LI D N,et al. GSDME mediates cas‐
               2014,20(34):5416-5429.                              pase-3-dependent pyroptosis in gastric cancer[J]. Biochem
          [10]  DIAS  CÂMARA  D  A,LUIZ  DE  SÁ  JUNIOR  P,        Biophys Res Commun,2018,495(1):1418-1425.
               ALEXANDRE DE AZEVEDO R,et al. Identification of   [20]  BEECK  K  O  D,VAN  CAMP  G,THYS  S,et  al.  The
               very small cancer stem cells expressing hallmarks of pluri‐  DFNA5 gene,responsible for hearing loss and involved in
               potency in B16F10 melanoma cells and their reoccurrence   cancer,encodes a novel apoptosis-inducing protein[J]. Eur
               in  B16F10-derived  clones[J].  Exp  Cell  Res,2020,391  J Hum Genet,2011,19(9):965-973.
              (2):111938.                                     [21]  XIA X J,WANG X,CHENG Z,et al. The role of pyropto‐
          [11]  ZHAO  Z  Y,ZENG  J  H,GUO  Q,et  al.  Berberine  sup‐  sis  in  cancer:pro-cancer  or  pro-“host”? [J].  Cell  Death
               presses  stemness  and  tumorigenicity  of  colorectal  cancer   Dis,2019,10(9):650.
               stem-like  cells  by  inhibiting  m A  methylation[J].  Front    (收稿日期:2024-01-04  修回日期:2024-03-19)
                                       6
               Oncol,2021,11:775418.                                                              (编辑:舒安琴)
          [12]  SAYGIN C,MATEI D,MAJETI R,et al. Targeting cancer
























          · 1450 ·    China Pharmacy  2024 Vol. 35  No. 12                            中国药房  2024年第35卷第12期
   39   40   41   42   43   44   45   46   47   48   49